Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19773098 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults
Condition: Influenza
Interventions: Biological: Aluminum hydroxide;   Biological: Inactivated Vero cell based whole virus influenza A/H5N1;   Drug: Placebo

Indicates status has not been verified in more than two years